Information about ExpressMedsCanada.to
List of countries where we can ship Gefitinib:
Latest news releases on Gefitinib:
Gefitinib (ZD1839) (INN, / ɡ ɛ ˈ f ɪ t ɪ n ɪ b /, trade name Iressa) is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor ...
Wirkmechanismus. Gefitinib hemmt vor allem die Tyrosinkinasen aus der EGFR-Familie (Epidermal Growth Factor Receptor, Rezeptor für den Epidermiswachstumsfaktor).
Iressa is used in the treatment of non-small cell lung cancer. Learn about side effects, interactions and indications.
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer n engl j med 362;25 nejm.org june 24, 2010 2381 N on–small-cell lung cancer is a
學名：Gefitinib. 商品名：Iressa® Tablet. 中文名：艾瑞莎膜衣錠. 作用機轉：不是造成細胞直接的毒殺，而是對於癌症的發展生長 ...
Background Most patients with non–small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor ...
Each tablet contains 250 mg of gefitinib. Excipients with known effect: Each tablet contains 163.5 mg of lactose (as monohydrate). Each tablet contains 3.86 mg of sodium.
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer.
Evidence-based recommendations on erlotinib (Tarceva) and gefitinib (Iressa) for treating locally advanced or metastatic non‑small‑cell lung cancer
Interstitial lung disease (ILD)which may be acute in onset, has been observed in 1.3% of patients receiving gefitinib, and some cases have been fatal (see section4.8).